Johnson & Johnson $103.41

down -0.78


22/8/2014 12:20 PM  |  NYSE : JNJ  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get JNJ Trend Analysis - it has underperformed the S&P 500 by 5%

Partner Headlines

  1. #PreMarket Primer: Friday, August 22: Draghi, Yellen Set To Speak At Jackson ...

    Benzinga
  2. Illumina lines up key partners

    IBD
  3. Apple Stock Held By Institutional Investors Rises

    IBD
  4. A Few Reasons Why Investors Should Consider Dendreon for Their Portfolio

    GuruFocus
  5. Robert Wood Johnson's New Industry Made Surgery Safer

    IBD
  6. Earnings Season Is The Right Prescription For Health Care ETFs

    Benzinga
  7. Intercept Pharma Soars On Liver-Disease Drug Data

    IBD
  8. Medivation Cancer Drug Fuels Beat, Swings To Profit

    IBD
  9. 3 Companies That Should Benefit From The New Initiative In Africa

    Benzinga
  10. #PreMarket Primer: Thursday, August 7: Russia Set To Release A List Of ...

    Benzinga
  11. 5 Dividend Stocks Delivering The Secret To Successful Investing

    GuruFocus
  12. 5 Dividend Stocks Delivering The Secret To Successful Investing

    GuruFocus
  13. Amgen Cancer Drug Kyprolis Succeeds In Trial

    IBD
  14. Why Procter & Gamble Surged Higher On Friday?

    GuruFocus
  15. Outlook for August 2014

    GuruFocus
  16. Pharmacyclics Q2 Earnings Get Mixed Reception

    IBD
  17. Unique 3D Startups And The Public Companies That Should Buy Them

    Benzinga
  18. Merck, J&J, Baxter Provide Healthy Dividend Stream

    IBD
  19. Limiting Risk: A Little Exposure To High Yield Goes A Long Way

    GuruFocus
  20. What's the Right PE Ratio?

    GuruFocus
  21. Omnicom Tops Forecasts Despite Failed Publicis Merger

    IBD
  22. BlackRock: Stocks Iffy, But Not These Pockets

    YCharts
  23. YTD Biggest Buyback Companies Trailing S&P In Stock Appreciation

    Benzinga
  24. Just Post-It: 3M Is a Good Bet for Your Portfolio Today

    GuruFocus
  25. Organovo Up 19% #PreMarket; In Research Pact With Johnson & Johnson Unit

    Benzinga
  26. ...

    GuruFocus
  27. Alexion, 3 Other Top Biotechs Reporting Earnings

    IBD
  28. The 10 Most-Respected Corporate Brands

    Benzinga
  29. Stocks To Watch For July 22, 2014

    Benzinga
  30. Why Has Wall Street Punished Johnson & Johnson For Its Earnings Beat?

    Benzinga
  31. #PreMarket Primer: Friday, July 18: Tension Between Russia And The West ...

    Benzinga
  32. Johnson & Johnson CEO: No Plans to Leave U.S.

    FoxBusiness
  33. Which Matters More: Janet Yellen Or Earnings & Economic Data?

    Benzinga
  34. Morgan Stanley Sees Meaningful '15 Headwind For Johnson & Johnson

    Benzinga
  35. Video; J&J Earnings Beat Estimates, But Guidance Mixed

    IBD
  36. Goldman Sachs, JPMorgan Chase Report Strong Earnings; Retail Numbers Fall ...

    Benzinga
  37. U.S. Stocks Sink; JPMorgan Shares Surge On Upbeat Earnings

    Benzinga
  38. J&J Earnings Beat Estimates, But Guidance Mixed

    IBD
  39. Markets Rise; Goldman Sachs Profit Beats Estimates

    Benzinga
  40. Stock Indexes Open Higher, Then Sag To Near Break-Even

    IBD
  41. Johnson & Johnson, Goldman Sachs Pushing These ETFs Upward

    Benzinga
  42. Stock Futures Up Modestly; Goldman, JPMorgan Top Estimates

    IBD
  43. UPDATE: Johnson & Johnson Posts Upbeat Q2 Earnings, Lifts Outlook

    Benzinga
  44. US Stock Futures Mostly Higher Ahead Of Goldman Sachs Earnings

    Benzinga
  45. #PreMarket Primer: Tuesday, July 15: Citigroup Settles Mortgage Probe

    Benzinga
  46. Earnings Scheduled For July 15, 2014

    Benzinga
  47. Stocks To Watch For July 15, 2014

    Benzinga
  48. Benzinga Weekly Preview: Earnings Season Kicks Into High Gear

    Benzinga
  49. J.P. Morgan: Johnson & Johnson's Drug Segment May Beat Q2 Street Views

    Benzinga
  50. The Power of a Photo Op, Or Lack Thereof

    FoxBusiness
Trading Center